ID: ALA1253908
Chembl Id: CHEMBL1253908
PubChem CID: 52944880
Max Phase: Preclinical
Molecular Formula: C17H10F6O3
Molecular Weight: 376.25
Molecule Type: Small molecule
Associated Items:
Synonyms: 4-Formylbenzyl 3,5-Bis(Trifluoromethyl)Benzoate | CHEMBL1253908|4-Formylbenzyl 3,5-Bis(Trifluoromethyl)Benzoate
Canonical SMILES: O=Cc1ccc(COC(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1
Standard InChI: InChI=1S/C17H10F6O3/c18-16(19,20)13-5-12(6-14(7-13)17(21,22)23)15(25)26-9-11-3-1-10(8-24)2-4-11/h1-8H,9H2
Standard InChI Key: FNLXZGFLVHKLTR-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 376.25 | Molecular Weight (Monoisotopic): 376.0534 | AlogP: 4.89 | #Rotatable Bonds: 4 |
| Polar Surface Area: 43.37 | Molecular Species: ┄ | HBA: 3 | HBD: ┄ |
| #RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.17 | CX LogD: 5.17 |
| Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.43 | Np Likeness Score: -0.46 |
| 1. Ohgane K, Dodo K, Hashimoto Y.. (2010) Retinobenzaldehydes as proper-trafficking inducers of folding-defective P23H rhodopsin mutant responsible for retinitis pigmentosa., 18 (19): [PMID:20805032] [10.1016/j.bmc.2010.08.014] |
| 2. Pasqualetto G, Pileggi E, Schepelmann M, Varricchio C, Rozanowska M, Brancale A, Bassetto M.. (2021) Ligand-based rational design, synthesis and evaluation of novel potential chemical chaperones for opsin., 226 [PMID:34555613] [10.1016/j.ejmech.2021.113841] |
Source(1):
